EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy

Karen Jackson iD, Maytal Shabat-Simon iD, Jonathan Bar-On, Rafi Steckler iD, Soliman Khatib iD, Snait Tamir iD, Paula Adriana Pitashny iD

Biomolecules · 2025

DOI: 10.3390/biom15050654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Karen Jackson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences and Technology, Tel-Hai College, Tel-Hai 1220800, Israel. Hauptthemen laut MEDLINE: Anticonvulsants, Cannabis, Plant Extracts, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a widespread neurological disorder that remains a critical global public health challenge. While numerous antiepileptic drugs (AEDs) are available, many patients either fail to achieve adequate seizure control or experience significant side effects. One promising alternative is pure cannabidiol (CBD), but using a whole cannabis extract may be equally effective and preferred for some patients. In the current study, we employed the pentylenetetrazole (PTZ)-induced hyperactivity model in zebrafish to compare the effects of CBD with various cannabis extracts. We evaluated three cannabis strains, each subjected to three different extraction methods, and benchmarked the results against the commercially available AED valproic acid (VPA). Our findings revealed that 5.7 µg/mL of CBD and 10 µg/mL of different extracts significantly reduced movement compared to PTZ and VPA. In addition, effective extracts produced effects similar to pure CBD despite containing much lower molecule levels. These results reinforced and expanded previous evidence supporting the clinical potential of both CBD and whole cannabis extracts for seizure control while suggesting a possible entourage effect. Further research is necessary to determine which patients may benefit more from pure CBD versus those who might prefer whole cannabis extracts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsCannabisPlant ExtractsEpilepsyAnimalsZebrafishDisease Models, AnimalCannabidiolPentylenetetrazoleValproic AcidSeizures

Stichwörter der Autor:innen

CBDcannabis extractsentourage effectepilepsyzebrafish

Substanzen

AnticonvulsantsPlant ExtractsCannabidiolPentylenetetrazoleValproic Acid

Autor:innen und Institutionen

  • Faculty of Sciences and Technology, Tel-Hai College, Tel-Hai 1220800, Israel.
  • MIGAL Galilee Research Institute, Kiryat Shmona 1101600, Israel.

ORCID-Profile: Karen Jackson, Maytal Shabat-Simon, Rafi Steckler, Soliman Khatib, Snait Tamir, Paula Adriana Pitashny

Zitieren

APA

Jackson, K., Shabat-Simon, M., Bar-On, J., Steckler, R., Khatib, S., Tamir, S., & Pitashny, P. A. (2025). The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy. Biomolecules. https://doi.org/10.3390/biom15050654

Vancouver

Jackson K, Shabat-Simon M, Bar-On J, Steckler R, Khatib S, Tamir S, et al. The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy. Biomolecules. 2025. doi:10.3390/biom15050654

BibTeX
@article{Jackson2025,
  author = {Jackson, Karen and Shabat-Simon, Maytal and Bar-On, Jonathan and Steckler, Rafi and Khatib, Soliman and Tamir, Snait and Pitashny, Paula Adriana},
  title = {The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050654}
}
Kostenlos starten →